News

January 8, 2020

IntegriChain Supported 65+ Life Sciences Launches in Last 36 Months

IntegriChain today announced that the company has supported more than 65 launches of innovative therapies including cell and gene therapy (CGT) and orphan & rare diseases (ORD) during the last three years. Emerging Life Sciences manufacturers have engaged IntegriChain for its best-in-class comprehensive commercialization platform, including channel and patient data stewardship and managed services to stand up their business infrastructure for all aspects of patient access: contracts and pricing, gross-to-net, channel, and patient services.


December 3, 2019

IntegriChain Implements Data-Science-Driven Stewardship of Specialty Pharmacy Data for Multiple Top-30 Life Sciences Manufacturers

IntegriChain announced that multiple top-30 Life Sciences manufacturers have implemented its stewardship and refining solutions to improve the quality and actionability of specialty pharmacy data. These solutions, based on recent data science advancements in the ICyte Platform, overcome the industry challenge of immature patient data sets that includes non-standardize data from hundreds of data suppliers delivered with varied quality. IntegriChain Co-Founder and EVP Josh Halpern will present more on this topic during his presentation, “The State of Patient Status Visibility and the Use of Artificial Intelligence to Drive Specialty Channel Insights,” at CBI Trade & Channel, beginning today in Philadelphia.


November 12, 2019

IntegriChain Gross-to-Net Automation Goes Live with Akcea Therapeutics

IntegriChain completes implementation of its Gross-to-Net (GTN) Managed Services with Akcea Therapeutics. IntegriChain GTN Solutions, which are built to industry best practices and are scalable and auditable, deliver end-to-end revenue management for Life Sciences Market Access and Finance teams that improves forecast accuracy, GTN modeling, and financial close efficiency. IntegriChain also is finalizing the implementation-readiness process for five additional GTN Managed Services customers. 



November 1, 2019

IntegriChain Presents Annual Customer Awards to Akcea Therapeutics, GSK, Johnson & Johnson and Spark Therapeutics

IntegriChain presented its annual customer awards last week at the Access Insights Conference. The company awards included Best Commercialization Launch awarded to Spark Therapeutics, the Trade & Channel Innovator awarded to GSK, and the Trailblazer of the Year awarded to Akcea Therapeutics. An individual award, the ICyte Power User Award, was presented to Allyson S. Johnston, Manager, Trade & Patient Access Analytics, for Johnson & Johnson.






adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article